9.23
Orthofix Medical Inc stock is traded at $9.23, with a volume of 322.65K.
It is down -1.91% in the last 24 hours and down -23.15% over the past month.
Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two reportable segments: Global Spine and Global Limb Reconstruction. The Global Spine segment offers bone growth therapies, spinal implants, biologics, and enabling technologies used in spinal procedures. The Global Limb Reconstruction segment provides products and solutions for limb deformity correction, limb lengthening, fracture management, and limb preservation, supported by digital technologies. It generates the majority of its revenue from the Global Spine segment.
See More
Previous Close:
$9.41
Open:
$9.41
24h Volume:
322.65K
Relative Volume:
0.91
Market Cap:
$373.09M
Revenue:
$825.37M
Net Income/Loss:
$-60.01M
P/E Ratio:
-6.1447
EPS:
-1.5021
Net Cash Flow:
$-4.46M
1W Performance:
-5.14%
1M Performance:
-23.15%
6M Performance:
-40.34%
1Y Performance:
-12.26%
Orthofix Medical Inc Stock (OFIX) Company Profile
Name
Orthofix Medical Inc
Sector
Industry
Phone
214-937-2000
Address
3451 PLANO PARKWAY, LEWISVILLE, TX
Compare OFIX vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
OFIX
Orthofix Medical Inc
|
9.23 | 371.88M | 825.37M | -60.01M | -4.46M | -1.5021 |
|
ABT
Abbott Laboratories
|
88.50 | 154.45B | 45.13B | 6.28B | 7.38B | 3.5895 |
|
SYK
Stryker Corp
|
301.14 | 118.05B | 25.27B | 3.34B | 4.57B | 8.6334 |
|
MDT
Medtronic Plc
|
78.14 | 103.20B | 36.36B | 4.84B | 5.43B | 3.7212 |
|
BSX
Boston Scientific Corp
|
44.95 | 69.50B | 20.62B | 3.56B | 3.48B | 2.3847 |
|
EW
Edwards Lifesciences Corp
|
86.68 | 49.68B | 6.30B | 1.07B | 1.09B | 1.8406 |
Orthofix Medical Inc Stock (OFIX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-27-26 | Initiated | TD Cowen | Hold |
| Oct-28-25 | Resumed | Stifel | Buy |
| Jan-22-25 | Initiated | Canaccord Genuity | Buy |
| Nov-08-24 | Upgrade | Stifel | Hold → Buy |
| May-08-24 | Upgrade | ROTH MKM | Neutral → Buy |
| Oct-20-23 | Initiated | ROTH MKM | Neutral |
| Sep-12-23 | Downgrade | BTIG Research | Buy → Neutral |
| Sep-12-23 | Downgrade | Stifel | Buy → Hold |
| Jul-19-23 | Resumed | BTIG Research | Buy |
| Mar-04-22 | Upgrade | Stifel | Hold → Buy |
| Oct-20-20 | Initiated | Stifel | Hold |
| Oct-29-19 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Jun-01-18 | Initiated | Cantor Fitzgerald | Overweight |
| Jun-21-17 | Initiated | BTIG Research | Buy |
| Jun-14-17 | Initiated | Ladenburg Thalmann | Buy |
| May-23-17 | Initiated | SunTrust | Buy |
| Jul-10-15 | Initiated | Sidoti | Buy |
| May-09-13 | Downgrade | Mizuho | Buy → Neutral |
| Jan-08-13 | Reiterated | Mizuho | Buy |
| Jun-21-10 | Initiated | Boenning & Scattergood | Outperform |
| Mar-09-10 | Reiterated | Jefferies & Co | Buy |
| Feb-18-10 | Upgrade | Susquehanna Financial | Neutral → Positive |
| Jan-22-10 | Initiated | Jefferies & Co | Buy |
| Nov-03-09 | Upgrade | Wells Fargo | Underperform → Market Perform |
| Jul-31-09 | Reiterated | Jefferies & Co | Buy |
| Jul-31-09 | Upgrade | Thomas Weisel | Market Weight → Overweight |
| May-26-09 | Reiterated | Jefferies & Co | Buy |
| Apr-17-09 | Downgrade | Wachovia | Mkt Perform → Underperform |
| Feb-19-09 | Initiated | Canaccord Adams | Buy |
| Jul-07-08 | Downgrade | Wachovia | Outperform → Mkt Perform |
View All
Orthofix Medical Inc Stock (OFIX) Latest News
Director equity grant at Orthofix Medical (OFIX) totals 14,965 units - Stock Titan
Orthofix (OFIX) director awarded 14,965 deferred stock units as equity grant - Stock Titan
Orthofix (NASDAQ: OFIX) awards 14,965 deferred stock units to director - Stock Titan
Orthofix (OFIX) director Michael Finegan receives 20,721 deferred units - Stock Titan
Director at Orthofix (OFIX) awarded 14,965 deferred stock units - Stock Titan
Orthofix Medical (OFIX) director granted 14,965 deferred stock units as equity award - Stock Titan
Orthofix Medical (OFIX) awards 14,965 deferred stock units to director Burris - Stock Titan
[Form 4] Orthofix Medical Inc. Insider Trading Activity - Stock Titan
Orthofix (OFIX) awards director Michael Paolucci 14,965 deferred stock units - Stock Titan
Orthofix (NASDAQ: OFIX) adds 1.25M shares to employee stock plan - Stock Titan
Orthofix reshuffles spine division leadership, posts preliminary Q1 sales - MSN
Did Orthofix Medical Inc. Insiders Breach their Fiduciary Duties to Shareholders? - GuruFocus
How The Orthofix Medical (OFIX) Narrative Is Resetting After CMS Cuts And Guidance Changes - Yahoo Finance
Orthofix Medical Inc. Common Stock (DE) (OFIX) Stock Price Today & Analysis - Gotrade
Orthofix Medical Inc at TD Cowen Healthcare Conference Transcript - GuruFocus
Juniper Investment Company, LLC Increases Stake in Orthofix Medi - GuruFocus
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Orthofix - TMX Newsfile
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Orthofix - TMX Newsfile
What's Driving the Activist Pressure on Orthofix Medical (OFIX) - Kavout
Orthofix Medical and 5 More Stocks See Action From Activist Investors - Barron's
Juniper investment, 10% owner, sells $2.59m Orthofix medical shares By Investing.com - Investing.com India
Orthofix Medical and 5 More Stocks See Action From Activist Investors -- Barrons.com - Moomoo
Juniper-managed funds trim Orthofix (OFIX) stake with 242K-share sale - Stock Titan
Juniper Investment Company (NASDAQ: OFIX) discloses indirect 10% Orthofix stake - Stock Titan
Orthofix Medical Inc. Q1 2026 earnings preview - MSN
Orthofix Medical Hits 52-Week Low at $9.52 Amidst Market Challenges - MarketsMojo
Orthofix Medical Hits 52-Week Low at $9.16 Amidst Ongoing Struggles - MarketsMojo
Orthofix Medical Hits 52-Week Low at $9.47 Amid Declining Profits - MarketsMojo
Juniper group discloses 11% Orthofix Medical (OFIX) stake and new share buys - Stock Titan
Law firm investigates Orthofix Medical for possible director breaches affecting shareholders - Pluang
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Orthofix Medical Inc. (NASDAQ: OFIX) - PR Newswire
Discipline and Rules-Based Execution in OFIX Response - Stock Traders Daily
Orthofix (OFIX) Q1 2026 Earnings Transcript - AOL.com
Orthofix lowers outlook on Medicare changes to bone growth stimulators - MSN
CCORF Maintains Orthofix Medical(OFIX.US) With Buy Rating, Maintains Target Price $20 - Moomoo
OFIX Maintains Rating by Barrington Research -- Price Target Low - GuruFocus
Stifel cuts Orthofix Medical stock price target on reimbursement hit By Investing.com - Investing.com South Africa
Barrington Adjusts Price Target on Orthofix Medical to $15 From $17, Maintains Outperform Rating - Moomoo
Stifel cuts Orthofix Medical stock price target on reimbursement hit - Investing.com
TD Cowen cuts Orthofix Medical stock price target on CMS rate cuts By Investing.com - Investing.com South Africa
TD Cowen cuts Orthofix Medical stock price target on CMS rate cuts - Investing.com UK
Canaccord cuts Orthofix Medical stock price target on reimbursement headwinds By Investing.com - Investing.com South Africa
Canaccord cuts Orthofix Medical stock price target on reimbursement headwinds - Investing.com Australia
Orthofix (OFIX) Faces Financial Outlook Adjustment Following FDA Reclassification - GuruFocus
Orthofix (OFIX) Lowers FY Revenue Outlook, Shares Plunge - GuruFocus
Orthofix Medical Inc Stock (OFIX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Orthofix Medical Inc Stock (OFIX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Engine Capital Management, LP | 10% Owner |
May 05 '26 |
Buy |
11.99 |
112,950 |
1,354,587 |
3,783,131 |
| Engine Capital Management, LP | 10% Owner |
May 06 '26 |
Buy |
12.23 |
41,946 |
512,916 |
3,821,285 |
| Engine Capital Management, LP | 10% Owner |
May 07 '26 |
Buy |
12.18 |
30,000 |
365,425 |
3,848,573 |
| Cedron Jorge Andres | CLO |
Apr 16 '26 |
Sale |
12.82 |
3,743 |
47,985 |
59,006 |
| Vitale Lucas | CP&BOO |
Mar 17 '26 |
Sale |
11.92 |
4,269 |
50,886 |
160,449 |
| CAPPS VICKIE L | Director |
Mar 09 '26 |
Buy |
12.48 |
2,500 |
31,200 |
25,085 |
| CAPPS VICKIE L | Director |
Mar 10 '26 |
Buy |
12.45 |
2,500 |
31,124 |
27,585 |
| Andrews Julie | CFO |
Mar 04 '26 |
Sale |
12.92 |
2,425 |
31,322 |
91,109 |
| Andrews Julie | CFO |
Mar 05 '26 |
Sale |
12.55 |
2,363 |
29,658 |
88,746 |
| Vitale Lucas | CP&BOO |
Mar 04 '26 |
Sale |
12.92 |
1,171 |
15,125 |
165,859 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):